Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

CordenPharma Adds Commercial Aseptic Fill–Finish Capacity and R&D Lab
By

By
  Dr. Stephen HouldsworthVice President, Global Head of Platform Management & MarketingCordenPharma International CordenPharma is proceeding with an approximate EUR 30-million ($33-million) investment at its CordenPharma Caponago injectable drug-product facility…

Biocon Investing $100 Million in New Fermentation-Based API Mfg Facility
By

By
  Prasad BSVChief Operating OfficerBiocon Limited Biocon is investing $100 million in a new fermentation-based production facility for drugs substances and intermediates. Prasad BSV, Chief Operating Officer (COO), Biocon, detailed…

DCAT Value Chain Insights – Now a Podcast!
By

By
Podcast Recordings Listen to specially selected articles from our website that feature in-depth analysis on the issues impacting the business of pharmaceutical development and manufacturing.           Blockbuster…

2020 VCI Editorial Calendar
By

By
Topics of Discussion: Through expert interviews, discussions, and market analysis, DCAT Value Chain Insights provides need-to-know information to keep pace with a changing marketplace: Market Watch: Tracking the performance of…

Thermo Fisher Scientific Investing $150 Million in Sterile Injectables Development and Manufacturing
By

By
  Marshall CrewGroup Vice President, StrategyThermo Fisher Scientific Thermo Fisher Scientific is investing $150 million to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing. Marshall…

Servier CDMO Invests $55 Million for Bioproduction and $7 Million for Industrial Prep Chromatography
By

By
  Gwenael Servant, PhDSenior Director, Servier Contract ManufacturingServier CDMO Servier CDMO, the contract development and manufacturing organization of the French pharmaceutical company, Servier, is investing $55 million for biologic-based drug-substance…

Seqens Investing $30 Million to Expand High-Potency Manufacturing
By

By
  Frederic DesdouitsManaging Director CDMOSEQENS Seqens, a contract development and manufacturing organization of pharmaceutical synthesis services and provider of specialty ingredients, is expanding high-potency manufacturing at its facilities in France.…

New CDMO Selkirk Pharma Investing $30 Million in Aseptic Fill–Finish Facility
By

By
  Patrick HaffeyCEOSelkirk Pharma Selkirk Pharma, a recently formed contract development and manufacturing organization, is investing $30 million for a new aseptic fill–finish facility in Washington State. Patrick Haffey, Chief…

SCHOTT Plans $1-Billion Expansion in Pharma Packaging
By

By
  Stefan-Marc SchmidtVice President, Marketing & SalesSCHOTT AG SCHOTT, a specialty glass and materials company, is making a $1-billion investment through 2025 in its global pharmaceutical packaging business. Stefan-Marc Schmidt,…

Lonza Updates $100-Million Expansion for High-Potency APIs and Small-Molecule Mfg
By

By
  Lee NewtonVice President & Business Unit Head, API Development & Manufacturing Lonza Pharma & Biotech Lee Newton, Vice President, Business Unit Head, API Development & Manufacturing, Lonza Pharma &…